⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 17 minutes ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 32 in last 7 days 🍎 Food: 1 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 17 minutes ago
🛡️ EUSW
🇬🇧
💊 Medicine EU September 23, 2022

Actilyse and Actilyse Cathflo

📷 Wikipedia: Alteplase · Source
Actilyse and Actilyse Cathflo
📷 Wikipedia: Alteplase · Source
INN
alteplase
Forms
Powder and solvent for solution for injection/infusion
Strengths
10 mg (Actilyse);20 mg (Actilyse);50 mg (Actilyse);2 mg (Actilyse Cathflo)
Area
Myocardial Infarction
Alternatives
Yes
🗄
Archived (older alert)
This alert was reported 1449 days ago and has been moved from our active feed to the archive. The original safety information still applies — we have no confirmation from the issuing agency that the product is safe again. Refer to the official notice for the current status.
📈 Timeline
114 days in total
May 20, 2026 September 11, 2026
Daily snapshot data starts accumulating once the scheduler runs — for now this is interpolated from the agency's first/last dates.

What is this? Actilyse is a medicine called alteplase. It is used in hospitals to treat heart attacks and other serious clots.

What's happening? There is a short supply of Actilyse in the EU. Hospitals may have less of it for now.

Does this affect me? If you need this medicine for a heart attack or clot, your doctor will decide what to use instead.

What should I do? Do not stop or change your treatment. Ask your doctor or pharmacist for advice.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Active substance(s)
Brand(s) / product name(s)
Agency-published detail

INN: alteplase · Forms: Powder and solvent for solution for injection/infusion · Strengths: 10 mg (Actilyse);20 mg (Actilyse);50 mg (Actilyse);2 mg (Actilyse Cathflo) · Area: Myocardial Infarction · Alternatives: Yes

First published
September 23, 2022
Last refreshed by us
3 months ago
Severity (as classified)
Medium
Official source
http://www.ema.europa.eu/en/medicines/human/shortages/actilyse-actilyse-cathflo

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

❓ Frequently asked questions

What is this medicine shortage alert about?
Actilyse and Actilyse Cathflo. INN: alteplase · Forms: Powder and solvent for solution for injection/infusion · Strengths: 10 mg (Actilyse);20 mg (Actilyse);50 mg (Actilyse);2 mg (Actilyse Cathflo) · Area: Myocardial Infarction · Alternatives: Yes
When was this alert issued?
This alert was issued on September 23, 2022 by EMA (European Medicines Agency).
Which countries are affected?
The alert applies to the entire EU.
How serious is this alert?
Medium risk. A medium risk means harm is possible under certain conditions. Read the notice and act on the recommended steps.
What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
Where can I find the official notice?
The full official notice is published on www.ema.europa.eu.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.